BG
Bob G Gower
Director

Bob G Gower insider trades: Ensysce Biosciences (ENSC) stock buys and sales

Director, Ensysce Biosciences Last trade Aug 7, 2026 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$444K
Bought, last 12 months
1 buy
13
Open-market trades
since 2007
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Bob reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 7, 2026ENSC↑ Buy$444K
Mar 2, 2023ENSC↑ Buy$44K
Mar 1, 2023ENSC↑ Buy$182K
Dec 9, 2022ENSC↑ Buy$500K
Jan 6, 2015MILL↑ Buy$43K
Dec 22, 2014MILL↑ Buy$76K
Sep 22, 2014MILL↑ Buy$101K
Apr 17, 2014MILL↑ Buy$53K
Nov 13, 2013KEX↓ Sell$2.4M
Feb 9, 2012KEX↓ Sell$871K
Feb 8, 2012KEX↓ Sell$1.0M
Feb 6, 2008KEX↓ Sell$2.8M
Nov 28, 2007KEX↓ Sell$456K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Bob G Gower's insider trades

Bob G Gower is a director at Ensysce Biosciences (ENSC). Since Nov 28, 2007, Bob has reported 8 open-market purchases worth $1.4M and 5 sales worth $7.6M on SEC Form 4. In the last 12 months: 1 buy ($444K).

Their filings also include grants and awards (16 filings), gifts (5 filings), option exercises (5 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENSC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.